Inpare ApS: Financial statements 2021
CVR: 37138789
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Inpare ApS (CVR 37138789) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -97,888 and a net result of DKK -76,644 compared with DKK -132,844 the year before. Equity in the 2021 report amounted to DKK -319,974.
- Gross Profit
- DKK -97,888
- Profit/Loss
- DKK -76,644
- Equity
- DKK -319,974
- Total Assets
- DKK 88,831
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -98K | -77K | -320K | - |
| 2020 | - | -197K | -133K | -243K | 2 |
| 2019 | - | -100K | -78K | -110K | 2 |
| 2018 | - | -27K | -26K | -33K | 2 |
| 2017 | 0 | -168K | -133K | -6K | 0 |
Official annual report
Find more companies like Inpare ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Inpare ApS has published its annual report for 2020. Gross profit came to DKK -197,084, and the net result was DKK -132,844.
About Inpare ApS
Inpare ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 27 November 2024. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Lionheart Pharmaceuticals ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -218,796 and a net result of DKK -272,847 compared with DKK -142,714 the year before. Equity in the 2023 report amounted to DKK -735,535.